CAROLYN MENSE: Open Payments
NPI 1568054757 · SHAWNEE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,445 in 78 payments from 19 companies in 2025. Trend: 2023 $1,902 · 2024 $2,417 · 2025 $1,445
Food & beverage: $1,445
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 9 | $204 |
| Amgen Inc. | 12 | $198 |
| ABBVIE INC. | 11 | $175 |
| Incyte Corporation | 10 | $168 |
| PFIZER INC. | 6 | $113 |
| LEO Pharma Inc. | 4 | $83 |
| Galderma Laboratories, L.P. | 5 | $80 |
| Almirall LLC | 4 | $75 |
| Janssen Biotech, Inc. | 3 | $64 |
| Novartis Pharmaceuticals Corporation | 3 | $61 |
Products named: Bimzelx, OTEZLA, OPZELURA, CIBINQO, SKYRIZI, RINVOQ, TREMFYA, Sotyktu.
Industry payments across KS — which companies pay providers there.
